Neoadjuvant Immunotherapy Efficacy: Enhancing T...

By João L. Carapinha

April 15, 2025

A recently published study examines the effectiveness of neoadjuvant immunotherapy efficacy in treating head and neck squamous cell carcinoma (HNSCC). It compares three treatment regimens: anti-PD-1 monotherapy (nivolumab), nivolumab combined with...